Last reviewed · How we verify

NCT04247139

Kefir Cholesterol Lowering Pilot Study

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing Kefir in Hypercholesterolemia in 21 participants. Completed in 16 September 2022.

Timeline
7 July 2020
Primary endpoint
25 April 2022
16 September 2022

Quick facts

Lead sponsorUniversity of Alberta
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment21
Start date7 July 2020
Primary completion25 April 2022
Estimated completion16 September 2022
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Alberta

Who can join

Adults 18 to 65, male only, with Hypercholesterolemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High cholesterol (a type of fat in humans blood) may be one factor that can lead to heart disease. If people have higher cholesterol, it is possible that kefir (a food similar to yogurt) may help to control blood cholesterol levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Kefir

Trials testing the same drug.

Other recruiting trials for Hypercholesterolemia

Currently open trials in the same condition.

Other University of Alberta trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04247139.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing